← Evidence map

ArticleFuture science OA2021

Early clinical and metabolic response to tazemetostat in advanced relapsed INI1 negative epithelioid sarcoma.

Ghazal Tansir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33815821